Fidelity Investments’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90K | Sell |
8,015
-1,412,976
| -99% | -$15.9M | ﹤0.01% | 3653 |
|
|
2025
Q1 | $6.49M | Buy |
1,420,991
+4,226
| +0.3% | +$19.3K | ﹤0.01% | 2062 |
|
|
2024
Q4 | $7.99M | Sell |
1,416,765
-2,228
| -0.2% | -$12.6K | ﹤0.01% | 2014 |
|
|
2024
Q3 | $6.87M | Buy |
1,418,993
+3,873
| +0.3% | +$18.7K | ﹤0.01% | 2045 |
|
|
2024
Q2 | $6.91M | Sell |
1,415,120
-1,962,354
| -58% | -$9.58M | ﹤0.01% | 1979 |
|
|
2024
Q1 | $44.9M | Sell |
3,377,474
-67,096
| -2% | -$891K | ﹤0.01% | 1366 |
|
|
2023
Q4 | $48M | Sell |
3,444,570
-3,132,992
| -48% | -$43.7M | ﹤0.01% | 1309 |
|
|
2023
Q3 | $87.2M | Buy |
6,577,562
+531,182
| +9% | +$7.04M | 0.01% | 1036 |
|
|
2023
Q2 | $113M | Sell |
6,046,380
-780,437
| -11% | -$14.6M | 0.01% | 933 |
|
|
2023
Q1 | $98.4M | Sell |
6,826,817
-78,606
| -1% | -$1.13M | 0.01% | 991 |
|
|
2022
Q4 | $134M | Sell |
6,905,423
-576,927
| -8% | -$11.2M | 0.01% | 851 |
|
|
2022
Q3 | $257M | Buy |
7,482,350
+2,166,571
| +41% | +$74.4M | 0.03% | 583 |
|
|
2022
Q2 | $81.2M | Buy |
5,315,779
+199,869
| +4% | +$3.05M | 0.01% | 1047 |
|
|
2022
Q1 | $117M | Buy |
5,115,910
+114,427
| +2% | +$2.61M | 0.01% | 1011 |
|
|
2021
Q4 | $184M | Buy |
5,001,483
+1,519,602
| +44% | +$56M | 0.01% | 835 |
|
|
2021
Q3 | $164M | Buy |
3,481,881
+32,087
| +0.9% | +$1.51M | 0.01% | 886 |
|
|
2021
Q2 | $208M | Buy |
+3,449,794
| New | +$208M | 0.02% | 813 |
|